Agilent price target lowered to $100 from $105 at Barclays

Barclays lowered the firm’s price target on Agilent to $100 from $105 and keeps an Underweight rating on the shares post the fiscal Q4 report. While the Q1 guidance “feels very conservative given the macro,” the rest of the year implies significant sequential step-ups that are at the high end if not above historical ranges, the analyst tells investors in a research note. As such, the firm says that while Agilent’s setup is favorable through the Q1 print given a lack of downside, there is little in terms of upside potential to estimates.